Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-12

Clinical Trial Update: GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

View source ↗

Summary

Post-approval study for Janssen Diagnostics' GeneSearch BLN Assay in breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GeneSearch Breast Lymph Node (BLN) Assay

Snippet

Sponsor: Janssen Diagnostics, LLC | Conditions: Breast Cancer | Status: TERMINATED